|
APPL2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.155300E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.997300E-03 |
| Normal-vs-Stage2 |
4.981500E-02 |
| Normal-vs-Stage3 |
2.619400E-04 |
| Normal-vs-Stage4 |
2.456000E-03 |
| Stage1-vs-Stage2 |
9.743400E-01 |
| Stage1-vs-Stage3 |
1.601430E-01 |
| Stage1-vs-Stage4 |
4.034000E-01 |
| Stage2-vs-Stage3 |
3.486800E-01 |
| Stage2-vs-Stage4 |
5.085200E-01 |
| Stage3-vs-Stage4 |
8.164000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.778300E-03 |
| Normal-vs-AfricanAmerican |
3.712000E-02 |
| Normal-vs-Asian |
8.022200E-03 |
| Caucasian-vs-AfricanAmerican |
8.563600E-01 |
| Caucasian-vs-Asian |
6.129200E-01 |
| AfricanAmerican-vs-Asian |
8.466400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.378640E-03 |
| Normal-vs-Female |
1.018460E-03 |
| Male-vs-Female |
7.090400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.980500E-03 |
| Normal-vs-Age(41-60Yrs) |
2.757600E-03 |
| Normal-vs-Age(61-80Yrs) |
2.036200E-03 |
| Normal-vs-Age(81-100Yrs) |
9.323900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.765800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.618000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.074200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.188800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.820600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.046400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.347800E-02 |
| Classical-VS-Follicular |
7.132000E-02 |
| Classical-VS-Other |
2.880600E-01 |
| Classical-VS-Normal |
1.962370E-02 |
| Tall-VS-Follicular |
7.404000E-01 |
| Tall-VS-Other |
8.225400E-01 |
| Tall-VS-Normal |
1.015040E-03 |
| Follicular-VS-Other |
7.508800E-01 |
| Follicular-VS-Normal |
1.340570E-03 |
| Other-VS-Normal |
3.879700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.582610E-03 |
| Normal-vs-N1 |
4.1045999999989E-06 |
| N0-vs-N1 |
3.357600E-02 |
|
|
